Clinical trials: Hepatopancreaticobiliary (HPB) Malignancy
Hepatopancreaticobiliary (HPB) Malignancy, Surgery
The HepatoPancreaticoBiliary Resection Arginine Immunomodulation (PRIMe) Trial
This is a randomized controlled blinded superiority trial to evaluate the impact of perioperative immunosupplementation on immune function following resection for hepatopancreaticobiliary (HPB) malignancy.
- Trial name
- PRIMe (NCT04549662)
- Testing
- Active A, Active B, Lipid bolus
- Where
- 2 sites in Canada
- Volunteers
- 45 people
- Sponsor
- Sunnybrook Health Sciences Centre
Hepatopancreaticobiliary (HPB) Malignancy, Ovarian Cancer (OvCa)
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
In this 2-arm, non-randomized, phase II trial, the investigators will evaluate the efficacy and safety of comprehensive multimodal prehabilitation (CMMP) alone or in combination with planned neoadjuvant (NAT) in pre-frail/frail…
- Conditions
- Hepatopancreaticobiliary (HPB) Malignancy, Ovarian Cancer (OvCa), Kidney Cancers, Bladder Cancer
- Trial name
- NCT07050771
- Testing
- Comprehensive multimodal prehabilitation (CMMP)
- Where
- United States
- Volunteers
- 148 people
- Sponsor
- The Methodist Hospital Research Institute
Cancer
Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery
This is a pilot study with the primary objective to validate the use of advanced minimally invasive hemodynamic monitoring with the PreSep™ Central Venous Oximetry Catheter, the Vigileo™ monitor, and FloTrac™ sensor for…
- Trial name
- NCT03612687
- Testing
- Minimally invasive hemodynamic monitoring
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Wake Forest University Health Sciences
Hepatopancreaticobiliary (HPB) Malignancy, Gall Bladder Cancer
Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
1. In biliary tract malignancies, achieving a microscopically clear resection margin (R0) is considered the only treatment for a cure. 2.
- Conditions
- Hepatopancreaticobiliary (HPB) Malignancy, Gall Bladder Cancer, Bile Duct Cancer, Pancreatoduodenectomy
- Trial name
- HPD_single (NCT06631352)
- Testing
- Hepatopancreatoduodenectomy
- Volunteers
- 50 people
- Sponsor
- Seoul National University Hospital